Associate Professorships (x2) in Systems Biology and Cancer Biology at the University of Pavia, Italy
The Department of Molecular Medicine at the University of Pavia is a large Department hosting approximately 30 research groups which are active in both preclinical and clinical research programmes in the fields of: (i) genetic diseases of the heart, bone and nervous system, (ii) degenerative diseases such as amyloidosis, Parkinson’s and Alzheimer caused by protein misfolding, (iii) cancer and (iv) tissue and organ regeneration. The Department received core funding from the Italian Ministry for Universities and Research under the recent Departments of Excellence Initiative , coordinates a new international PhD Programme in Translational Medicine and has access to state of the art equipment for molecular and cellular research in the central University Core Equipment Facility including high performance computing, super resolution light microscopy, cryo electron microscopy, mass spectrometry, X-ray crystallography, cell sorting and pre-clinical in vivo imaging (MRI and micro-CT).
The Department seeks to appoint two new members of staff to the following tenured positions:
MM01. Associate Professorship in Systems Biology
The person appointed will have a strong track record in systems biology or related fields of research and will build a strong research programme involving both computational and experimental systems biology approaches (NMR, X-ray crystallography, mass spectrometry, etc) to the study of tissue/organ development, regeneration, inflammation, degenerative diseases or cancer.
MM02. Associate Professorship in Cancer Biology
The person appointed will have made original contributions to the molecular or cellular basis of cancer and will build a strong research programme in areas such as cancer genetics, epigenetics, progression, metastasis, microenvironment or cancer immunity.
The gross annual salary for both position is in the range of €52,107 to € 94,568 depending on age and seniority. Appointees to these positions may be entitled to a special tax rate that exempts them from income tax for the first six years of work in Italy.
The positions are partly funded by the Italian Ministry of Universities and Research and it is a requirement for application that candidates:
(i) are currently employed in an Institution located outside Italy;
(ii) have held the position of Associate Professor at the University where they are currently employed or a role of equivalent seniority at a Research Institute for three years or more;
(iii) meet standard metrics thresholds regularly used for academic appointments and promotions at Italian Universities. Appointees at Associate Professor level in the Systems Biology area are expected to have authored 8 or more papers in the last 5 years, to have received 284 or more citations in the last 10 years and to have an h-Index of 9 or higher over the last 5 years. Appointees at Associate Professor level in the Cancer Biology area are expected to have authored 10 or more papers in the last 5 years, to have received 323 or more citations in the last 10 years and to have an h-Index of 10 or higher over the last 5 years.
Appointees are expected to contribute to the teaching of undergraduate medical students enrolled in the Harvey Course , a leading medicine degree course of the University of Pavia taught in English. They will have access to a pool of internal studentships and post-doctoral fellowships offered on an annual and competitive basis by the University of Pavia and are expected to secure external funding for their research programmes from national and international sources of funding.
Informal enquiries about these positions or other group leader positions available at the Department of Molecular Medicine at the University of Pavia can be obtained from E Gherardi .
Formal applications including a full academic cv, the name of three people familiar with the work of the candidate and a brief (< 2,500 words) programme of research should be submitted by email to S Burgess by the 31st of July 2020. The selection procedure will involve an interview and a research seminar. The starting date is negotiable but will have to be before 1 November 2021.